Few subjects have been more controversial than ivermectin and hydroxychloroquine — two long-established, inexpensive medications widely and successfully used in many parts of the world for the prevention and treatment of COVID. Yet, health care providers across the U.S. are being threatened with discipline for using these off-label medicines for their COVID patients. On Oct. […]
Articles
- « Go to Previous Page
- Go to page 1
- Interim pages omitted …
- Go to page 77
- Go to page 78
- Go to page 79